ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

Pardanani A, Lasho TL, Finke CM, et al.

Br J Haematol · 2016

Grade Bcohort
DOI ↗PubMed ↗

Key Findings

  • ●ASXL1 and CBL mutations independently predict inferior survival in AdvSM

Referenced in (1 disease)

Systemic Mastocytosis
ID: pmid-26628266DOI: 10.1111/bjh.13888PMID: 26628266